VisEn Medical

VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence

VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence Molecular Tomographic (FMT) imaging systems and vivo imaging agents provide fluorescence molecular imaging performance in identifying, characterizing, and quantifying various ranges of disease biomarkers and therapeutic efficacy in vivo. It also provides ReninSense680, an imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo; and VivoTagR 680 XL fluorescent dye for labeling biomolecules in a range of in vitro and in vivo imaging applications. In addition, the company offers fluorescence tomographic imaging systems.